HCA Healthcare, Inc. (LON:0J1R)
476.14
+7.10 (1.51%)
At close: Nov 7, 2025
HCA Healthcare Revenue
HCA Healthcare had revenue of $19.16B USD in the quarter ending September 30, 2025, with 9.57% growth. This brings the company's revenue in the last twelve months to $74.37B, up 6.82% year-over-year. In the year 2024, HCA Healthcare had annual revenue of $70.60B with 8.67% growth.
Revenue (ttm)
$74.37B
Revenue Growth
+6.82%
P/S Ratio
1.49
Revenue / Employee
$235.35K
Employees
316,000
Market Cap
82.61B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 70.60B | 5.64B | 8.67% |
| Dec 31, 2023 | 64.97B | 4.74B | 7.86% |
| Dec 31, 2022 | 60.23B | 1.48B | 2.52% |
| Dec 31, 2021 | 58.75B | 7.22B | 14.01% |
| Dec 31, 2020 | 51.53B | 197.00M | 0.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
HCA Healthcare News
- 8 days ago - HCA Healthcare, Inc. to Present at November Healthcare Conferences - Business Wire
- 9 days ago - Decoding HCA Healthcare Inc (HCA): A Strategic SWOT Insight - GuruFocus
- 10 days ago - If You Invested $1000 in HCA Healthcare 10 Years Ago, This Is How Much You'd Have Now - Nasdaq
- 10 days ago - New Strong Buy Stocks for Oct. 30: HTBK, HCA, and More - Nasdaq
- 11 days ago - Analyst Jefferies Raises HCA Price Target to $525, Maintains Buy Rating | HCA Stock News - GuruFocus
- 11 days ago - 3 Reasons Growth Investors Will Love HCA (HCA) - Nasdaq
- 12 days ago - HCA Healthcare (HCA) Announces Proposed Public Offering of Senior Unsecured Notes - GuruFocus
- 12 days ago - HCA Healthcare (HCA) Sees Raised Price Target by B of A Securities | HCA Stock News - GuruFocus